Ibrance (palbociclib)
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for Ibrance (palbociclib), covering 2017-11-06 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: Validation of Capillary Microsampling for Therapeutic Drug Monitoring of CDK4/6 Inhibitors in Breast Cancer Patients (TDHOME) [NA]